Drug Topics

MARCH 14, 2025

This years meeting will take place from March 21 to 24 in Nashville, Tennessee.

316

316

The Checkup by Singlecare

MARCH 14, 2025

If youre one of the 47 million Americans who take a medication to treat high cholesterol, you may have heard of pravastatin , a statin drug that is approved by the Food and Drug Administration (FDA) to lower bad cholesterol levels and help prevent heart disease. While pravastatin, also sold under the brand name Pravachol, does not directly cause weight gain, some people may notice slight changes in their weight after starting the medication.

FDA 71

FDA 71

Drug Topics

MARCH 14, 2025

A new report from the American Economic Liberties Project presents the continued challenges pharmacies face since Congress failure to pass PBM reform at the end of 2024.

247

247

Hospital Pharmacy Europe

MARCH 14, 2025

The triple combination medicine deutivacaftor/tezacaftor/vanzacaftor (brand name Alyftrek) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for treating eligible patients with cystic fibrosis. This is a once-daily, next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator treatment.

Hospitals 52

Hospitals 52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

MARCH 14, 2025

George Van Antwerp, MBA, senior vice president of Product Innovation and Strategic Planning at Prime Therapeutics, discusses how pharmacists can help patients decide which digital tools are best for them.

247

247

Fierce Healthcare

MARCH 14, 2025

Amid a growing measles outbreak in west Texas and New Mexico, many doctors and nurses are fielding questions from patients about an infectious diseases they have never seen, until now.

124

124

Pharmacy Times

MARCH 14, 2025

Tarlatamab was approved by the FDA in May 2024 for patients who progressed after platinum-based chemotherapy.

Chemotherapy 109

Chemotherapy FDA 109

Drug Topics

MARCH 14, 2025

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed the common trends in GLP-1 use shes seen amongst her patients as well as her extensive experience working with this medication class.

247

247

Hospital Pharmacy Europe

MARCH 14, 2025

We are excited to share that the latest Clinical Excellence in Respiratory Care event will take place virtually on 7 May 2025. This free, one-day conference is a must-attend event for healthcare professionals looking to stay informed on the latest clinical advancements in respiratory care. Led by esteemed experts from recognised Centres of Excellence and NHS Trusts across the UK, the event offers valuable insights, evidence-based strategies, and real-world case studies to enhance patient outcome

Hospitals 52

Hospitals Patient Care 52

Drug Topics

MARCH 14, 2025

Additional data shows that an investigational drug, given every 4 months with Apretude, kept viral levels suppressed for patients who were already on stable treatment.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

MARCH 14, 2025

The venture aims to advance MeiraGTxs Parkinsons gene therapy through Phase III trials with up to $430m in funding from Hologen.

101

101

Drug Topics

MARCH 14, 2025

These findings are shared as late-breaking data at the 32nd Conference on Retroviruses and Opportunistic Infections (CROI) being held in San Francisco, California.

247

247

The Thyroid Pharmacist

MARCH 14, 2025

I have some exciting news to share Ive officially launched The Thyroid Pharmacist Healing Conversations Podcast! If youve ever struggled with frustrating thyroid symptoms, felt lost in your healing journey, or wondered whether there was a better way to support your health, this podcast is for you. Over the past decade, Ive dedicated my life to understanding the root causes of Hashimotos researching, experimenting, and finding what truly works.

Immunization 52

Immunization 52

STAT

MARCH 14, 2025

Psshh. Psshh. Psshh.  The steady push of air from a CPAP machine can be lifesaving for people with sleep apnea. It also provides health care professionals with a stream of information that ensures a person is breathing through the night.

87

87

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

MARCH 14, 2025

Pharmacists play an essential role in counseling patients on biosimilar substitution protocols and following state regulations regarding interchangeable medications.

82

82

pharmaphorum

MARCH 14, 2025

The FDA has released its recommendations on the composition of influenza vaccines for the 2025-26 season, without the input of its external advisors

Vaccines 80

Vaccines FDA 80

Pharmacy Times

MARCH 14, 2025

The authors note that further research is needed to clarify cost-effectiveness, long-term adherence, and psychosocial impacts of oral immunotherapy.

81

81

Fierce Healthcare

MARCH 14, 2025

Follow along today for ongoing coverage of Dr. Ozs confirmation hearing in front of the Senate Finance Committee. It is likely he will be asked about cuts to Medicaid, potential conflicts of interest, his views on Medicare Advantage and more.

76

76

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

MARCH 14, 2025

Lipid metabolism plays a critical role in the function of T-cells.

73

73

Fierce Healthcare

MARCH 14, 2025

Teladoc Health has added digital health companies specializing in digestive health, fertility and specialty care to its connect care program. Primary care doctors have a strong interest in adopting AI, but most want more training and medico-legal protections before they trust AI tools at work, a recent survey found.

63

63

Pharmacy Times

MARCH 14, 2025

Alcohol consumption, though typically associated with adverse health outcomes, could be associated with reduced low-density lipoprotein cholesterol (LDL-C) and improved high-density lipoprotein cholesterol (HDL-C).

65

65

Fierce Healthcare

MARCH 14, 2025

A second federal judge has instructed the government to reinstate fired probationary workers, this time including the HHS in the ruling. Futures RIFs are to be put on hold if they do not comply with the law, but the department appears to be gearing up for more terminations despite the roadblock.

63

63

Pharmacy Times

MARCH 14, 2025

Pharmacists with a deeper knowledge of xerostomia are ideally positioned to help educate patients with dry mouth on making informed self-care decisions for effective symptom management and improved quality of life.

65

65

Fierce Healthcare

MARCH 14, 2025

The company, which runs six hospitals, cited recent years' rising costs and "plateaued" reimbursement. It said it has sufficient cash on hand to fund operations at its hospitals during the proceedings.

Hospitals 60

Hospitals 60

Pharmacy Times

MARCH 14, 2025

The new data emphasize the fundamental differences in management and associated complications with each form of diabetes.

65

65

Pharmaceutical Technology

MARCH 14, 2025

The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European Union.

59

59

Pharmacy Times

MARCH 14, 2025

Matthew Zirwas, MD, addresses the significant financial burden associated with the medication, emphasizing the importance of pharmacists in navigating prior authorizations and access patient support programs.

65

65

Pharmaceutical Technology

MARCH 14, 2025

Boehringer Ingelheim and Sweden-based Salipro Biotech have entered a research and licence agreement for drug targets' development.

59

59

pharmaphorum

MARCH 14, 2025

As the news that NHS England is to be dismantled sinks in, the British Medical Association (BMA) and other bodies have weighed in on the decision

59

59

Pharmaceutical Technology

MARCH 14, 2025

AstraZenecas senior director in oncology data science outlined how the company uses AI for drug discovery at a recent talk.

59

59

pharmaphorum

MARCH 14, 2025

The UK pharma sector has reacted with consternation to the government's proposal to raise the Statutory Scheme rate to 32.

59

59

Pharmaceutical Commerce

MARCH 14, 2025

The latest news for pharma industry insiders.

59

59

pharmaphorum

MARCH 14, 2025

Sutro has shelved its lead drug for ovarian cancer and turned its attention to three preclinical candidates in a major shake-up of its business.

59

59